Capsule
- π¦Became a unicornApr 2021
- πPeak valuation$1.15 Billion β21
- πBecame a UnitardFeb 2023
- πΈLast valuation~$575M
The rise & fall
5 moments Β· 2015β2023The key moments, with employee sentiment along the way.
π¬ entries paraphrase anonymous, unverified reviews posted publicly on Glassdoor β; dated facts carry their source.
How it happened
Capsule is a New York-based digital pharmacy that delivers prescriptions to customers' doors. Pandemic-era demand propelled it past a $1B valuation in April 2021 with a $300M Series D from Durable Capital, T. Rowe Price, Whale Rock and Baillie Gifford.
As growth stalled in the 2022-23 downturn, it cut about 13% of staff and raised a Series E in early 2023 at roughly half its $1.2B peak β a steep down round.
Source: The Information (Feb 2023): raising ~$500M, ~half its $1.2B peak
Founder
Current roles as self-reported on LinkedIn, retrieved 2026-08-19. See our methodology.
Disclosed investors (25)
Historical funding participation; lists may be incomplete and do not establish current ownership or investor losses.
* Lead in a funding round Β· Crunchbase β Β· 2026-10-13 Β· Methodology Β· Leaderboard


